andrew azman @andrewazman.bsky.social Profile
andrew azman @andrewazman.bsky.social

@andrewazman

Followers
1K
Following
2K
Statuses
1K

infectious disease epidemiologist with @JHIDDynamics, @JohnsHopkinsSPH, @gcevd and @MSF

geneva, switzerland
Joined July 2008
Don't wanna be here? Send us removal request.
@andrewazman
andrew azman @andrewazman.bsky.social
4 months
RT @MusoleBugeme: Today, I shared insights on the Mpox outbreak and its management challenges in Uvira, eastern 🇨🇩, at the @gcevd's monthly…
0
9
0
@andrewazman
andrew azman @andrewazman.bsky.social
5 months
Discussing how we use results on impact of water supply improvements and vaccination on guiding the fight against #cholera in DRC and beyond.
1
0
2
@andrewazman
andrew azman @andrewazman.bsky.social
5 months
RT @EckerleIsabella: We are looking for a #consultant to develop, implement & validate #diagnostic assays for emerging viruses @gcevd. Requ…
0
26
0
@andrewazman
andrew azman @andrewazman.bsky.social
6 months
Nous recherchons un scientifique motivé pour aider à gérer une étude à Uvira en RDC sur l'épidémiologie du #choléra et l'impact des #vaccins avec @LSHTM @JHIDDynamics @ctdgh_ucb @TempleUniv @Inrb_goma. Veuillez m'envoyer un message direct ou email pour plus de détails.
4
4
18
@andrewazman
andrew azman @andrewazman.bsky.social
9 months
RT @gcevd: Our Centre has a new direction: Prof. @EckerleIsabella is the new director & Dr. Pauline Vetter the new deputy director of the C…
0
11
0
@andrewazman
andrew azman @andrewazman.bsky.social
10 months
Have some microbiology skills and want to work with us on a fun cholera project?
@espoir_bwenge
Espoir Bwenge Malembaka
10 months
A great opportunity to work with @jackie_knee @PseudoClo @LSHTM_EHG in collaboration with our team @JHIDDynamics @andrewazman @MusoleBugeme Job Opportunity at LSHTM: Research Fellow (Maternity Cover)
0
2
5
@andrewazman
andrew azman @andrewazman.bsky.social
1 year
RT @NatureMedicine: Integrated analysis of clinical, serological and behavioral data estimate that current clinical surveillance systems on…
0
5
0
@andrewazman
andrew azman @andrewazman.bsky.social
1 year
RT @TaraHegde: 1/ Our latest work on #cholera burden in an endemic region in Bangladesh in @NatureMedicine with @icddr_b and @dr_firdausi @…
0
4
0
@andrewazman
andrew azman @andrewazman.bsky.social
1 year
RT @julienpotet: While #cholera rages in many countries, there isn't any single dose of oral cholera vaccine left today in the emergency st…
0
17
0
@andrewazman
andrew azman @andrewazman.bsky.social
1 year
RT @Epicentre_MSF: 👏🏽Here the 1st research paper @PLOSNTDs on the 1st mass vaccination campaign against hepatitis E, which took place in th…
0
4
0
@andrewazman
andrew azman @andrewazman.bsky.social
1 year
Hope to see more of these types of simple descriptive analyses from recent outbreaks with high CFR in Africa so we can make progress towards the @SecGTFCC End Cholera Roadmap.
0
0
2
@andrewazman
andrew azman @andrewazman.bsky.social
1 year
Nice thread on new evidence on 1-dose protection from #cholera #vaccine and the current global supply context.
@espoir_bwenge
Espoir Bwenge Malembaka
1 year
Thrilled to see our work coming out in the @TheLancetInfDis . Effectiveness of one dose of killed oral cholera vaccine in an endemic community in the Democratic Republic of the Congo: a matched case-control study -"
0
0
6
@andrewazman
andrew azman @andrewazman.bsky.social
1 year
RT @espoir_bwenge: Thrilled to see our work coming out in the @TheLancetInfDis . Effectiveness of one dose of killed oral cholera vaccine i…
0
10
0
@andrewazman
andrew azman @andrewazman.bsky.social
1 year
RT @IVIHeadquarters: 📢 IVI and EuBiologics are thrilled to announce that Euvichol-S, a simplified formulation of Euvichol-Plus® oral choler…
0
5
0
@andrewazman
andrew azman @andrewazman.bsky.social
1 year
@niamhtumelty @snsf_ch @niamhtumelty at least from my experience in public health and epidemiology, it is not one single publisher but more or less every special issue I have been involved with as an editor, reviewer, author has been below the quality of normal submissions (even w/ great journals)
1
0
0